Immunai

Immunai was established in December 2018. We are a diverse group of experts in the fields of immunology, genomics, computer science, engineering, mathematics, and operations, with a singular focus on tackling a bold challenge. Supported by prominent figures in the scientific community specializing in immunology, oncology, and single cell genomics, we are prepared for the undertaking. Immunai integrates extensive, multi-omic single cell genomics with state-of-the-art machine learning algorithms to facilitate detailed profiling of the immune system on a large scale and with rapid processing.